Financhill
Back

Aptevo Therapeutics Quote, Financials, Valuation and Earnings

Aptevo Therapeutics Price Quote

$0.18
+0.01 (+8.76%)
(Updated: September 19, 2024 at 6:55 PM ET)

Aptevo Therapeutics Key Stats

Sell
1
Aptevo Therapeutics (APVO) is a Sell

Day range:
$0.14 - $0.20
52-week range:
$0.14 - $21.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.02
P/B ratio:
0.35%

Volume:
4.8M
Avg. volume:
1.6M
1-year change:
-99.03%
Market cap:
$1.6M
Revenue:
$0
EPS:
$-46.96

How Much Does Aptevo Therapeutics Make?

Data Unavailable

Is Aptevo Therapeutics Growing As A Company?

Data Unavailable

Aptevo Therapeutics Stock Price Performance

What Is Aptevo Therapeutics 52-Week High & Low?

Aptevo Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aptevo Therapeutics?

Is Aptevo Therapeutics Cash Flow Positive?

  • What Is APVO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$24.3M
  • What Is Aptevo Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $11.4M
  • What Is Aptevo Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Aptevo Therapeutics Return On Invested Capital

Data Unavailable

Aptevo Therapeutics Earnings Date & Stock Price

Aptevo Therapeutics Competitors

Aptevo Therapeutics Dividend Yield

Aptevo Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 13.47%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 15.00
Upside from Last Price: 8963.44%

Major Shareholders

  • How many APVO shares are owned by institutional investors?
    2M APVO shares are owned by institutional investors
  • How many APVO shares are owned by insiders?
    0 APVO shares are owned by insiders